#mckessonideashare
©2024 McKesson Corporation. All rights reserved.
The Next Chapter: Regulatory Changes Shaping the Future of Pharmacy Practice
July 12 @ 8:45 am - 9:45 pm
The evolving regulatory landscape plays a crucial role in shaping pharmacy practice and patient care. This session will review key legislation, discuss anticipated policy changes, and explore strategies for effective advocacy and compliance to improve patient access and outcomes. Join us to gain insights on navigating regulatory shifts with confidence and contributing to a future of pharmacy practice that prioritizes high-quality patient care.
Pharmacist Learning Objectives
1. Review current regulations affecting pharmacy operations and patient care.
2. Discuss upcoming regulatory changes and their impact on patient access to services.
3. Explore the pharmacist’s role in advocating for regulations that improve patient care.
4. Identify compliance challenges with evolving regulations and possible patient-focused solutions.
5. Design a compliance plan that meets new regulatory requirements while prioritizing patient outcomes.
Technician Learning Objectives
1. Review current regulations affecting pharmacy operations and patient care.
2. Discuss upcoming regulatory changes and their impact on patient access to services.
3. Explore the pharmacist’s role in advocating for regulations that improve patient care.
4. Identify compliance challenges with evolving regulations and possible patient-focused solutions.
5. Design a compliance plan that meets new regulatory requirements while prioritizing patient outcomes.
Lecturer and Moderator
Marsha Millonig, MBA, BPharm
President & CEO
Catalyst Enterprises, LLC
Marsha Millonig is the President/CEO of Catalyst Enterprises, LLC, a health care consulting firm dedicated to creating change toward improved health outcomes. Marsha is also an associate fellow of the University of Minnesota College of Pharmacy’s Center for Leading Healthcare Change. Before starting her firm, Marsha was with the National Association of Chain Drug Stores (NACDS) and the Healthcare Distribution Management Association (HDMA, now HAD). She a practicing pharmacist and pharmacist immunizer as a relief pharmacist for community pharmacies in the Twin Cities. She co-authored a book with William Tindall, PhD on innovative pharmacist services called “Pharmaceutical Care: Insights from Community Pharmacists.” Her latest work, “100 MTM Tips for Pharmacists” is available as an e-book at the Apple Store, Amazon Kindle, Barnes and Noble and Kobo Canada.
Panelists:
Brooklyn Morgan, PharmD
Director of State Policy
National Alliance of State Pharmacy Associations (NASPA)
Brooklyn Morgan, PharmD, is the Director of State Policy at the National Alliance of State Pharmacy Associations (NASPA). An Alabama native, she graduated from Samford University’s McWhorter School of Pharmacy in 2023. Following her passion for advancing the pharmacy profession through policy and advocacy, Brooklyn relocated to Washington, D.C., to serve as the 2023-2024 Executive Resident at the National Community Pharmacists Association (NCPA). In her current role at NASPA, she engages with members and stakeholders to address the ongoing challenges pharmacists face. Brooklyn has been recognized for her professionalism and leadership, receiving the Joseph O. Dean Jr. Student Professionalism Award from the Alabama Pharmacy Association in 2022. Beyond her professional endeavors, she enjoys traveling and aims to visit 50 countries before turning 50, having already explored 17.
Randy P. McDonough, PharmD, MS, BCGP, BCPS, FAPhA
Co-Owner, Chief Executive Officer
Towncrest Pharmacy Corporation
President, American Pharmacists Association
Dr. Randy McDonough is Co-owner/CEO of Towncrest, Solon Towncrest, Towncrest LTC, Towncrest Wellness Apothecary, Bennett Pharmacy, and Cornerstone Apothecary Pharmacies. He is also co-founder/co-owner of Innovative Pharmacy Solutions and Professor of Pharmacy Management and Innovation at Loma Linda University School of Pharmacy. He is responsible for development, implementation, and quality assurance for all aspects of the clinic and services. He is board certified in geriatrics and as a pharmacotherapy specialist. His areas of interest include community-based outcomes research, student development, residency training, geriatrics, new business models for service delivery, and developing and implementing patient care services.
Greg Reybold, JD
Vice President of Healthcare Policy and General Counsel
American Pharmacy Cooperative, Inc. (APCI)
Greg Reybold is the Vice President of Healthcare Policy and General Counsel at the American Pharmacy Cooperative, Inc. (APCI), where he leads the development of healthcare policy and manages legal strategies at both state and federal levels. Prior to joining APCI in September 2021, Greg served as General Counsel and Vice President of Public Policy for the Georgia Pharmacy Association (GPhA), where he was instrumental in drafting pioneering legislation to regulate pharmacy benefit managers (PBMs), including the nation’s first Pharmacy Patient Protection Act in 2017 and anti-steering legislation in 2019. A graduate of Emory University School of Law, Greg is a recognized expert on PBM issues and has consulted with various organizations on related legislation. He is also active on social media, advocating for patient access to care, pharmacist support, and PBM reform.
Marsha Millonig reports she is a stockholder in Pfizer, Astra Zeneca, and Moderna. All relevant financial relationships have been mitigated.
Brooklyn Morgan has no relevant financial relationships with ineligible companies to disclose.
Randy McDonough has no relevant financial relationships with ineligible companies to disclose.
Greg Reybold reports that he is currently employed by APCI. All relevant financial relationships have been mitigated.
Financial support for this course was provided through an educational grant from McKesson Health Mart.
Pharmacist Universal Activity Number (UAN): 0107-0000-25-108-L03-P
Technician Universal Activity Number (UAN): 0107-0000-25-108-L03-T
Application-based activity
CPE Redemption:
To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), learners must participate in the course and complete the exam* and evaluation. Shortly after both the exam and evaluation are successfully completed and submitted, the CPE Statement of Credit can be accessed on CPE Monitor at www.MyCPEMonitor.net.
*CEimpact provides two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.